Cardioprotection with esmolol cardioplegia: Efficacy as a blood-based: Solution

European Journal of Cardio-thoracic Surgery

Volumn 43, Issue 3, 2013, Pages 619-627

  Fujii, Masahiro ^a,b   Chambers, David J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Blood perfusion; Cardioplegia; Cardioprotection; Esmolol; Function; Ischaemia reperfusion; Rat

Indexed keywords

ESMOLOL; ST THOMAS HOSPITAL SOLUTION;

ANIMAL TISSUE; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; CRYSTALLOID; DRUG EFFICACY; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART PROTECTION; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ANIMALS; CARDIOPLEGIC SOLUTIONS; CARDIOTONIC AGENTS; HEART; HEART ARREST, INDUCED; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; PROPANOLAMINES; RANDOM ALLOCATION; RATS; RATS, WISTAR; VENTRICULAR FUNCTION, LEFT;

EID: 84873629750     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezs365     Document Type: Article

References (21)

1. Chambers DJ, Fallouh HB. Cardioplegia and cardiac surgery: pharmacological arrest and cardioprotection during global ischemia and reperfusion. Pharmacol Ther 2010;127:41-52.
2. Khandoudi N, Percevault-Albadine J, Bril A. Comparative effects of carvedilol and metoprolol on cardiac ischemia-reperfusion injury. J Cardiovasc Pharmacol 1998;32:443-51.
3. Wiest D. Esmolol. A review of its therapeutic efficacy and pharmacokinetic characteristics. Clin Pharmacokinet 1995;28:190-202.
4. Kuhn-Regnier F, Natour E, Dhein S, Dapunt O, Geissler HJ, LaRose K et al. Beta-blockade versus Buckberg blood-cardioplegia in coronary bypass operation. Eur J Cardiothorac Surg 1999;15:67-74.
5. Mehlhorn U, Sauer H, Kuhn-Regnier F, Sudkamp M, Dhein S, Eberhardt F et al. Myocardial beta-blockade as an alternative to cardioplegic arrest during coronary artery surgery. Cardiovasc Surg 1999;7:549-57.
6. Mehlhorn U, Sudkamp M. Beta-blockade as an alternative to cardioplegia. Thorac Cardiovasc Surg 1998;46(Suppl 2):302-7.
7. Bessho R, Chambers DJ. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent. J Thorac Cardiovasc Surg 2001;122:993-1003.
8. Bessho R, Chambers DJ. Myocardial protection with oxygenated esmolol cardioplegia during prolonged normothermic ischemia in the rat. J Thorac Cardiovasc Surg 2002;124:340-51.
9. Chukwuemeka AO, Brown KA, Venn GE, Chambers DJ. Changes in P-selectin expression on cardiac microvessels in blood-perfused rat hearts subjected to ischemia-reperfusion. Ann Thorac Surg 2005;79:204-11.
10. Sutherland FJ, Hearse DJ. The isolated blood and perfusion fluid perfused heart. Pharmacol Res 2000;41:613-27.
11. Bergmann SR, Clark RE, Sobel BE. An improved isolated heart preparation for external assessment of myocardial metabolism. Am J Physiol 1979;236:H644-61.
12. Gorczynski RJ. Basic pharmacology of esmolol. Am J Cardiol 1985;56: 3F-13F.
13. Kloner RA, Kirshenbaum J, Lange R, Antman EM, Braunwald E. Experimental and clinical observations on the efficacy of esmolol in myocardial ischemia. Am J Cardiol 1985;56:40F-8F.
14. Sidi A, Davis RF. Esmolol decreases the adverse effects of acute coronary artery occlusion on myocardial metabolism and regional myocardial blood flow in dogs. Anesth Analg 1988;67:124-30.
15. Roth E, Torok B. Effect of the ultrashort-acting beta-blocker Brevibloc on free-radical-mediated injuries during the early reperfusion state. Basic Res Cardiol 1991;86:422-33.
16. Pirk J, Kellovsky P. An alternative to cardioplegia. Ann Thorac Surg 1995; 60:464-5.
17. Fukata M, Konishi T, Higuchi K, Akishima S. [A case of CABG under the cardiac arrest induced by a short acting beta-blocker without clamping the aorta]. Nippon Kyobu Geka Gakkai Zasshi 1997;45:1591-5.
18. Ede M, Ye J, Gregorash L, Summers R, Pargaonkar S, LeHouerou D et al. Beyond hyperkalemia: beta-blocker-induced cardiac arrest for normothermic cardiac operations. Ann Thorac Surg 1997;63:721-7.
19. Fallouh HB, Bardswell SC, McLatchie LM, Shattock MJ, Chambers DJ, Kentish JC. Esmolol cardioplegia: the cellular mechanism of diastolic arrest. Cardiovasc Res 2010;87:552-60.
20. Quon CY, Stampfli HF. Biochemical properties of blood esmolol esterase. Drug Metab Dispos 1985;13:420-4.
21. Quon CY, Mai K, Patil G, Stampfli HF. Species differences in the stereoselective hydrolysis of esmolol by blood esterases. Drug Metab Dispos 1988;16:425-8.